欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0363/001
药品名称Salofalk Granu-Stix 500 mg magensaftresistentes Retardgranulat
活性成分
    • mesalazine 500.0 mg
剂型Gastro-resistant prolonged release granules
上市许可持有人Dr. Falk Pharma GmbH Leinenweberstrasse 5 79108 Freiburg im Breisgau Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Cyprus (CY)
      Salofalk 500 mg prolonged-release granules
    • Latvia (LV)
      Salofalk 500 mg zarnās šķīstošās ilgstošās darbības granulas
    • Hungary (HU)
      SALOFALK 500 mg gyomornedv-ellenálló retard granulátum
    • Czechia (CZ)
      Salofalk 500mg gastro-resistant prolonged-release granules
    • Slovakia (SK)
    • Slovenia (SI)
    • United Kingdom (Northern Ireland) (XI)
    • Italy (IT)
    • Denmark (DK)
      Salofalk
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Mesagran 500 mg magensaftresistentes Retardgranulat
    • Spain (ES)
    • Portugal (PT)
      Salofalk Grânulos
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • France (FR)
    • Lithuania (LT)
许可日期2002/10/02
最近更新日期2024/05/23
药物ATC编码
    • A07EC02 mesalazine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase